| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 750335 | (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0181211508101519 | -0.18177145 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0181211508101519 | 0.062770381 |
| NSC 228155 | Null | 0.0187206825450445 | 0.42145299 |
| NSC 639517 | Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.0187206825450445 | 0.47737279 |
| NSC 120925 | Null | 0.0208632511155816 | 0.31918983 |
| NSC 132275 | Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) | 0.0208632511155816 | 0.39474986 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0208632511155816 | 0.25809446 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0208632511155816 | 0.095684465 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.0208632511155816 | 0.31504215 |
| NSC 208885 | Null | 0.0208632511155816 | -9.2397901e-005 |